Real-time 3D Simulation-based eTraining for Intensive Care Procedures on Mobile Devices

为应对COVID-19疫情，Epicardio着手将其独特的教育心脏模拟器扩展为“心肺”模块，适用于ICU程序的在线电子培训。我们建议开发基于实时3D模拟的电子培训应用程序，用于在移动的设备上访问ICU通气和临时心脏起搏。英国卫生大臣最近证实，4,500名退休医护人员已签约帮助抗击疫情。NHS将很快获得近10，000个新的重症监护病房。因此，所有专科的大量医生和护士目前都被转移到重症监护室管理。与此同时，年轻和缺乏经验的工作人员被部署在现有和新医院的新增加的ICU中，例如伦敦的NHS Nightingale，曼彻斯特，哈罗盖特等。机械通气和临时心脏起搏是ICU中对COVID-19急性呼吸窘迫综合征患者最关键的两种干预措施。显然，对这些ICU程序的快速临床培训的需求急剧增加。封锁和自我隔离也导致了对远程访问培训的额外需求。Epicardio eTraining应用程序将通过持续专业发展- CPD积分的独立认证。广泛的产品测试将在内部进行，并通过苹果和谷歌应用商店进行公开测试。这两个应用程序将可通过苹果和谷歌应用程序商店直接或机构批量购买。所有产品内容都有英语和德语版本。

In response to the COVID-19 pandemic, Epicardio sets out to expand its unique educational heart simulator into a "heart & lung" module, suitable for online eTraining in ICU procedures. We propose to develop realtime 3D simulation-based eTraining apps for ICU Ventilation and Temporary Cardiac Pacing accessible on mobile devices.The UK Health Secretary has recently confirmed that 4,500 retired healthcare workers have signed up to help battle the outbreak. The NHS will soon have access to nearly 10,000 new Intensive Care Units. As a result large numbers of doctors and nurses of all specialties are currently being diverted to ICU management. At the same time young and inexperienced staff are being deployed in the newly added ICU's in existing and new hospitals, such as the NHS Nightingale in London, Manchester, Harrogate, etc.Mechanical ventilation and temporary cardiac pacing are the two procedures with the most critical interventions in ICU for COVID-19 patients with acute respiratory distress syndrome. Evidently there is a sharp increase in demand for rapid clinical training for these ICU procedures. The lockdown and self-isolation have also caused additional demand for remotely accessible training.The Epicardio eTraining apps will be independently certified with Continuous Professional Development - CPD points. Extensive product testing will be conducted internally and through open public testing through Apple and Google App Stores. Both apps will be available for direct or institutional bulk purchase through Apple and Google App Stores. All product content with be made available in English and German languages.